What are the differential diagnoses for a patient presenting with tense or flaccid blisters and possible mucosal erosions suggestive of an autoimmune blistering disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differential Diagnoses for Autoimmune Blistering Disease

When evaluating a patient with tense or flaccid blisters and possible mucosal erosions, the primary differential diagnoses include Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), bullous pemphigoid, pemphigus vulgaris, mucous membrane pemphigoid, and several other autoimmune and drug-induced blistering disorders.

Primary Differential Diagnoses

Drug-Induced Severe Cutaneous Reactions

  • Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) 1

    • Presents with painful skin, atypical targets, purpuric macules, and epidermal detachment
    • Mucosal involvement at multiple sites (eyes, mouth, genitalia) is characteristic
    • Prodrome of fever, malaise, and upper respiratory symptoms typically precedes eruption
    • Critical distinction: Flaccid blisters with positive Nikolsky sign and skin pain are prominent features
    • Drug exposure within preceding 2 months is typical trigger
  • Erythema Multiforme Major (EMM) 1

    • Distinguished by typical target lesions or raised atypical targets on extremities
    • Less than 10% body surface area involvement
    • Usually triggered by HSV infection rather than drugs
    • Mucosal involvement present but less extensive than SJS/TEN

Autoimmune Subepidermal Blistering Diseases

  • Bullous Pemphigoid 2

    • Tense blisters on erythematous or normal-appearing skin (key distinguishing feature)
    • Predominantly affects elderly patients (>70 years)
    • Intense pruritus often precedes blistering by weeks to months
    • Oral involvement in 10-30% of patients, typically palatal mucosa
    • Urticarial or eczematous prodrome common
    • Direct immunofluorescence shows linear IgG/C3 at basement membrane zone
  • Mucous Membrane Pemphigoid 3, 4

    • Predominant mucosal involvement with potential for scarring complications
    • Can affect eyes (risk of blindness), oral cavity, pharynx, larynx, esophagus, and genitalia
    • Skin involvement occurs in minority of cases
    • Tense blisters when present
    • Linear IgG/C3 deposition at basement membrane zone on direct immunofluorescence

Autoimmune Intraepithelial Blistering Diseases

  • Pemphigus Vulgaris 5

    • Flaccid blisters that rupture easily (critical distinguishing feature)
    • Oral mucosa is first site of involvement in majority of cases
    • Mucosal erosions may precede skin involvement by months
    • Positive Nikolsky sign in uninvolved skin
    • Direct immunofluorescence shows intercellular IgG deposition (net-like pattern)
    • Peak incidence in third to sixth decades
  • Paraneoplastic Pemphigus 1

    • Associated with underlying malignancy (lymphoproliferative disorders most common)
    • Severe, refractory mucosal involvement
    • Polymorphous skin lesions
    • Respiratory involvement may occur

Other Important Differentials

  • Linear IgA Bullous Dermatosis 1

    • Can present with tense blisters
    • Only IgA on direct immunofluorescence (distinguishing feature)
    • May be drug-induced
  • Epidermolysis Bullosa Acquisita 2

    • Tense blisters on trauma-prone areas
    • Antibodies bind to floor of salt-split skin (vs. roof in bullous pemphigoid)
    • Scarring and milia formation
  • Bullous Lupus Erythematosus 1

    • Subepidermal blisters in patient with systemic lupus erythematosus
    • Photodistributed lesions
  • Generalized Bullous Fixed Drug Eruption 1

    • Recurrent blistering at same sites with drug re-exposure
    • Dusky erythema and post-inflammatory hyperpigmentation
  • Staphylococcal Scalded Skin Syndrome 6, 1

    • More superficial level of skin cleavage
    • Typically affects children
    • Positive bacterial cultures
  • Acute Generalized Exanthematous Pustulosis (AGEP) 7, 1

    • Numerous sterile pustules rather than true blisters
    • Rapid onset after drug exposure
    • Fever and neutrophilia

Diagnostic Approach Algorithm

Step 1: Assess Blister Characteristics

  • Tense blisters → Consider subepidermal disorders (bullous pemphigoid, mucous membrane pemphigoid, epidermolysis bullosa acquisita)
  • Flaccid blisters → Consider intraepithelial disorders (pemphigus vulgaris, paraneoplastic pemphigus)
  • Skin pain and fragility → Strongly suggests SJS/TEN

Step 2: Evaluate Mucosal Involvement

  • Multiple mucosal sites with severe involvement → SJS/TEN, pemphigus vulgaris, paraneoplastic pemphigus
  • Predominant mucosal disease with scarring → Mucous membrane pemphigoid
  • Limited oral involvement → Bullous pemphigoid, pemphigus vulgaris (early)

Step 3: Obtain Critical History

  • Recent drug exposure (within 2 months) → SJS/TEN, drug-induced linear IgA disease, bullous fixed drug eruption 1
  • Prodromal fever and malaise → SJS/TEN
  • Preceding intense pruritus → Bullous pemphigoid
  • Known malignancy → Paraneoplastic pemphigus

Step 4: Perform Diagnostic Testing 1

Essential biopsies:

  • Lesional skin biopsy for routine histopathology (from edge of fresh blister)
  • Perilesional skin biopsy for direct immunofluorescence (unfixed specimen)

Histopathology patterns:

  • Subepidermal cleft with eosinophils → Bullous pemphigoid
  • Full-thickness epidermal necrosis → SJS/TEN
  • Suprabasal acantholysis → Pemphigus vulgaris

Direct immunofluorescence patterns:

  • Linear IgG/C3 at basement membrane zone → Bullous pemphigoid, mucous membrane pemphigoid
  • Intercellular IgG (net-like) → Pemphigus vulgaris
  • Only IgA at basement membrane → Linear IgA disease

Additional testing:

  • Indirect immunofluorescence on salt-split skin differentiates roof-binding (bullous pemphigoid) from floor-binding (epidermolysis bullosa acquisita) antibodies 2
  • Serum autoantibody testing (ELISA for specific antigens)

Critical Pitfalls to Avoid

  1. Do not delay skin biopsy for direct immunofluorescence - This is essential for definitive diagnosis and can be performed after treatment initiation, though prolonged treatment reduces positive results 2

  2. Do not assume all blistering with mucosal involvement is pemphigus - SJS/TEN requires immediate drug discontinuation and different management approach 1

  3. Do not overlook drug history - Anticonvulsants, antibiotics, NSAIDs, and allopurinol are common SJS/TEN triggers 6, 1

  4. Do not confuse paracetamol/ibuprofen use for prodromal symptoms as causative agents - These are likely confounders in SJS/TEN, though reports exist 6

  5. In elderly patients with tense blisters and pruritus, bullous pemphigoid is statistically most likely - It is the most common autoimmune blistering disease in the West 2

  6. Oral-only presentation does not exclude serious disease - Both pemphigus vulgaris and mucous membrane pemphigoid commonly begin with isolated oral lesions 5, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.